跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT00178932
NCT00178932已完成不适用

Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors

Northwestern University2 个研究点 分布在 1 个国家目标入组 37 人开始时间: 1998年11月最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
37
试验地点
2
主要终点
We plan to compare the polymorphisms across schizophrenic patients and adults who do not have a diagnosed major mental illness. .
研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The goals of this study are to replicate previous findings of genetic predictors of response to clozapine and other antipsychotic drugs.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 65 Years（Adult, Older Adult）
性别
All
接受健康志愿者
是

入选标准

  • •Patients with the diagnoses of schizophrenia or schizoaffective disorder, and bipolar disorder or major depression with psychotic features, or volunteers with no history of a psychotic disorder.

排除标准

  • •Patients with DSM-IV diagnoses other than schizophrenia or schizoaffective disorder, and bipolar disorder or major depression with psychotic features.

结局指标

主要结局

We plan to compare the polymorphisms across schizophrenic patients and adults who do not have a diagnosed major mental illness. .

时间窗: single visit

次要结局

  • We will also evaluate relationships between the polymorphism and past and current mental health among the non-diagnosed sample(single visit)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

已完成
不适用
Program for the Introduction Into Clinical Practice of the Principles of Personalized and Preventive Medicine Based on the Isolation of Gene Polymorphism in Schizophrenia in People of the Kazakh Ethnic GroupSchizophrenia
NCT05090644Asfendiyarov Kazakh National Medical University700
已完成
不适用
A Study of Strategies to Improve Schizophrenia TreatmentSchizophreniaSchizoaffective Disorder
NCT00156637US Department of Veterans Affairs106
已完成
不适用
Improving Accessibility and Personalization of CR for SchizophreniaSchizophreniaSchizoaffective Disorder
NCT03576976New York State Psychiatric Institute67
已完成
不适用
Cognitive Remediation and Sheltered Employment in SchizophreniaChronic Schizophrenia
NCT01891929Hôpital le Vinatier79
Unknown
不适用
Novel Candidate Genes for Treatment Response to Antipsychotics in SchizophreniaSchizophrenia
NCT02205437Fundación Marques de Valdecilla200
Improving Outcome in Schizophrenia Through... | 临床试验